文献速递消化内镜消化道肿瘤与早癌

结直肠内镜黏膜切除术后瘢痕的内镜评估:何时需要活检(ESCAPE试验)

Endoscopic scar assessment after colorectal endoscopic mucosal resection scars: when is biopsy necessary (EMR Scar Assessment Project for Endoscope (ESCAPE) trial).
PubMed 文献 · Gut · 2019-01-11

这项前瞻性研究纳入230例患者共255处结直肠内镜黏膜切除(EMR)术后瘢痕,评估高清白光、窄带成像(NBI)及近聚焦(NF)等四种模式诊断复发腺瘤的价值。结果显示各模式诊断效能均高,NBI联合NF在高置信度病例中阴性预测值和敏感度均达100%,初始EMR使用钛夹会降低诊断准确性。作者认为高置信度NBI-NF阴性光学诊断无需活检,高置信度阳性可立即切除,低置信度仍需活检。

要点

  • 四种成像模式诊断EMR后复发腺瘤的阴性预测值≥97%、阳性预测值≥81%、敏感度≥90%、特异度≥93%、准确率≥93%。
  • 高置信度病例中NBI联合NF的阴性预测值为100%(95%CI 98%至100%),敏感度为100%(95%CI 93%至100%)。
  • 初始EMR使用钛夹增加诊断不准确(调整OR=1.68,95%CI 1.01至2.75)。

核心结论

  • 四种成像模式对EMR后复发肿瘤诊断的敏感度和准确率均很高,尤其是NBI联合NF。
  • 数据强烈提示,基于NBI-NF的高置信度阴性光学诊断,在结直肠EMR随访中无需活检确认无复发。
  • 高置信度阳性光学诊断可立即切除可疑区域;所有低置信度病例仍需活检。

研究设计与样本

  • 前瞻性研究,纳入接受大(≥20 mm)结直肠肿瘤EMR后结肠镜随访的患者。
  • 共纳入230例患者、255处EMR瘢痕;内镜医师用四种成像模式预测复发及置信度,另由26名经验丰富的内镜医师离线评估图像。

主要发现

  • 复发腺瘤患病率为24%。
  • 所有模式诊断效能高:阴性预测值≥97%、阳性预测值≥81%、敏感度≥90%、特异度≥93%、准确率≥93%。
  • 高置信度病例中,NBI联合NF的阴性预测值为100%(95%CI 98%至100%),敏感度为100%(95%CI 93%至100%)。
  • 初始EMR使用钛夹增加诊断不准确(调整OR=1.68,95%CI 1.01至2.75)。
  • 离线评估中,所有成像模式特异度均高(均值≥93%,范围55%至100%);NBI-NF敏感度为82%(72%至93%),显著高于白光(69%,38%至86%;p<0.001)、白光-NF(68%,55%至83%;p<0.001)和NBI(71%,59%至90%;p<0.001)。

关键数值与推荐

  • 高置信度NBI-NF阴性光学诊断:阴性预测值100%(95%CI 98%至100%),敏感度100%(95%CI 93%至100%)。
  • 初始EMR使用钛夹与诊断不准确相关:调整OR=1.68(95%CI 1.01至2.75)。
  • 离线评估NBI-NF敏感度82%(72%至93%),高于白光69%(38%至86%)、白光-NF 68%(55%至83%)、NBI 71%(59%至90%),p均<0.001。

临床怎么用

  • 作者认为,基于NBI-NF的高置信度阴性光学诊断,在结直肠EMR随访中无需活检确认无复发。
  • 作者认为,高置信度阳性光学诊断可立即切除可疑区域。
  • 作者认为,所有低置信度病例仍需活检。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: It is unclear whether endoscopic assessment of scars after colorectal endoscopic mucosal resection (EMR) has to include biopsies, even if endoscopy is negative. Vice versa, endoscopic diagnosis of recurrent adenoma may not require biopsy before endoscopic reinterventions. We prospectively analysed various endoscopic modalities in the diagnosis of recurrence following EMR. DESIGN: We conducted a prospective study of patients undergoing colonoscopy after EMR of large (≥20 mm) colorectal neoplasia. Endoscopists predicted recurrence and confidence level with four imaging modes: high-definition white light (WL) and narrow-band imaging (NBI) with and without near focus (NF). Separately, 26 experienced endoscopists assessed offline images. RESULTS: Two hundred and thirty patients with 255 EMR scars were included. The prevalence of recurrent adenoma was 24%. Diagnostic values were high for all modes (negative predictive value (NPV) ≥97%, positive predictive value (PPV) ≥81%, sensitivity ≥90%, specificity ≥93% and accuracy ≥93%). In high-confidence cases, NBI with NF had NPV of 100% (95% CI 98% to 100%) and sensitivity of 100% (95% CI 93% to 100%). Use of clips at initial EMR increased diagnostic inaccuracy (adjusted OR=1.68(95% CI 1.01 to 2.75)). In offline assessment, specificity was high for all imaging modes (mean: ≥93% (range: 55%-100%)), while sensitivity was significantly higher for NBI-NF (82%(72%-93%)%)) compared with WL (69%(38%-86%); p<0.001), WL-NF (68%(55%-83%); p<0.001) and NBI (71%(59%-90%); p<0.001). CONCLUSION: Our study demonstrates very high sensitivity and accuracy for all four imaging modalities, especially NBI with NF, for diagnosis of recurrent neoplasia after EMR. Our data strongly suggest that in cases of high confidence negative optical diagnosis based on NBI-NF, no biopsy is needed to confirm absence of recurrence during colorectal EMR follow-up. A high confidence positive optical diagnosis can lead to immediate resection of any suspicious area. In all cases of low confidence, biopsy is still required. TRIAL REGISTRATION NUMBER: NCT02668198.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Kandel P, Brand EC, Pelt J, et al. Endoscopic scar assessment after colorectal endoscopic mucosal resection scars: when is biopsy necessary (EMR Scar Assessment Project for Endoscope (ESCAPE) trial). Gut. 2019. PMID: 30635409. doi:10.1136/gutjnl-2018-316574

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。